Exploring how M1 aminopeptidases' conformational flexibility drives cancer progression and how scientists are designing inhibitors to target these molecular contortionists.
Exploring how tumor hypoxia corrupts the complement system to accelerate cancer progression and new therapeutic strategies targeting this axis.